Browsing: category: Psychedelics
DEA Boosts Psychedelics Production For Research, Cannabis Quotas Hold Steady Ahead Of Rescheduling
The Drug Enforcement Administration (DEA) has unveiled new production quotas for Schedule I and II controlled substances, with a notable…
In a dimly lit basement painted in deep forest green, Benji “Dez” Dezaval leads a small group in a discussion…
Bright Green To Supply DEA-Approved Cannabis Extracts And Psychedelics To FDA-Registered Pharmaceutical Company – Bright Green (NASDAQ:BGXX)
Bright Green Corporation BGXX has signed a letter of intent (LOI) to supply its DEA-approved cannabis extracts and plant-based psychedelics…
German Authorities Issue Warning About Gummies Containing The Hallucinogenic Amanita Muscaria Mushroom
The German Federal Office for Consumer Protection and Food Safety issued a warning against gummy bears containing the hallucinogenic fly…
The U.S. Food and Drug Administration (FDA) is on the verge of making a historic decision regarding the approval of…
The federal criminalization of marijuana has evidently failed, with recent reports indicating that 72% of the marijuana market in the…
The potential of MDMA-assisted therapy (MDMA-AT) for treating post-traumatic stress disorder (PTSD) has garnered significant attention, including many scientific studies…
A national drug policy reform organization is challenging the DEA’s proposal to ban two psychedelic substances, arguing the move would…